The enhancement use of neuropharmaceuticals: More scepticism and caution needed

Addiction

Volumn 105, Issue 12, 2010, Pages 2041-2043

  Hall, Wayne D ^a   Lucke, Jayne C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

COGNITION; DRUG CONTROL; DRUG EFFECT; EDITORIAL; HUMAN; OFF LABEL DRUG USE;

CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DRUG AND NARCOTIC CONTROL; HUMANS; OFF-LABEL USE;

EID: 78249262621     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03211.x     Document Type: Editorial

References (18)

1. Greely H., Sahakian B., Harris J., Kessler R. C., Gazzaniga M., Campbell P. et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008; 456: 702-5.
2. Sahakian B., Morein-Zamir S. Professor's little helper. Nature 2007; 450: 1157-9.
3. Larriviere D., Williams M. A., Rizzo M., Bonnie R. J. Responding to requests from adult patients for neuroenhancements guidance of the ethics, law and humanities committee. Neurology 2009; 73: 1406-12.
4. Bogle K. E., Smith B. H. Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr Drug Abuse Rev 2009; 2: 157-76.
5. Teter C. J., Falone A. E., Cranford J. A., Boyd C. J., McCabe S. E. Nonmedical use of prescription stimulants and depressed mood among college students: frequency and routes of administration. J Subst Abuse Treat 2010; 38: 292-8.
6. Academy of Medical Sciences. Brain Science, Addiction and Drugs. London: Academy of Medical Sciences; 2008. Available at: (accessed 13 September 2010; archived by webcite at ).
7. Outram S. M. The use of methylphenidate among students: the future of enhancement? J Med Ethics 2010; 36: 198-202.
8. De Jongh R., Bolt I., Schermer M., Olivier B. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev 2008; 32: 760-76.
9. Van Oorsouw K., Merckelbach H. Expectancies and memory for an emotional film fragment: a placebo study. Am J Psychol 2007; 120: 287-301.
10. Racine E., Forlini C. Expectations regarding cognitive enhancement create substantial challenges. J Med Ethics 2009; 35: 469-70.
11. Svetlov S. I., Kobeissy F. H., Gold M. S. Performance enhancing, non-prescription dose of Ritalin-a comparison with amphetamines and cocaine. J Addict Dis 2007; 26: 1-6.
12. Diller L. H. The run on ritalin: attention deficit disorder and stimulant treatment in the 1990s. Hastings Cent Rep 1996; 26: 12-8.
13. Advokat C. What exactly are the benefits of stimulants for ADHD? J Atten Disord 2009; 12: 495-8.
14. Singh I., Kelleher K. J. Neuroenhancement in young people: proposal for research, policy, and clinical management. AJOB Neurosci 2010; 1: 3-16.
15. Quednow B. B. Ethics of neuroenhancement: a phantom debate. BioSocieties 2010; 5: 153-6.
16. Hall W. Feeling 'better than well'-can our experiences with psychoactive drugs help us to meet the challenges of novel neuroenhancement methods? EMBO Rep 2004; 5: 1105-9.
17. Spillane J. F. Cocaine: From Medical Marvel to Modern Menace in the United States, 1884-1920. Baltimore: Johns Hopkins University Press; 2000.
18. Rasmussen N. On Speed: The Many Lives of Amphetamine. New York: New York University Press; 2008.